Assembly approves chapter amendment letting prescribers use practice name or address on abortion-medication labels

The New York State Assembly on the floor approved a chapter amendment to recent legislation on labels for mifepristone and misoprostol, allowing prescribers who choose not to display an individual clinician's name on a medication label to show the practice name or, in certain cases, the practice address.

Sponsor Assemblymember Reyes (speaker 7) told colleagues the amendment preserves the original bill's intent while adding a requirement that prescribers inform patients when they elect to use a practice name or address on the label. "We added notification for the patient," the sponsor said, arguing the change increases transparency for the person receiving care.

Opponents questioned whether replacing a clinician's name with a practice name or address could obscure who prescribed the medication when patients seek emergency care or when prescriptions cross state lines. "I will not support this legislation," said Assemblymember Pierzolo (speaker 8), who urged colleagues to consider court challenges and the public-safety implications of telehealth prescribing across states.

Supporters and the sponsor countered that pharmacies and state records retain prescriber information and that clinical care in emergencies does not rely on the prescriber's name on the bottle. "You will always be able to find who the prescriber is," the sponsor said, noting pharmacy records and state retention rules.

A party vote recorded the tally: ayes 96, noes 51. The Assembly announced the bill "will take effect immediately."